You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Promising early results for new ovarian cancer drug combo

Results from an early-stage clinical trial found a new combination of target drugs could provide a new treatment option for treatment-resistant advanced ovarian cancer.